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ABSTRACT  
Background: Maternal depressive symptoms during and after pregnancy predict poorer child 
neurodevelopment. The effects of timing, symptom severity and additive influences remain unclear.  
Methods: 2231 mothers of the Prediction and Prevention of Pre-eclampsia and Intrauterine Growth 
Restriction (PREDO) study completed the Center of Epidemiological Studies Depression Scale biweekly up to 
14 times during pregnancy and twice up to 12 months after pregnancy. At child’s age 1.9-5.7 years, the 
mothers completed the Beck Depression Inventory-II on their concurrent depressive symptoms and Ages 
and Stages Questionnaire on child developmental milestones. 
Results: Higher mean maternal depressive symptoms, each biweekly score and consistently clinically 
relevant symptomatology during pregnancy predicted lower total developmental milestones, fine and gross 
motor, communication, problem solving and personal/social skills scores in children. While maternal 
depressive symptoms up to 12 months after pregnancy and in early childhood also predicted lower 
developmental milestones scores, developmental milestones scores were the lowest in children whose 
mothers’ depressive symptoms were above the clinical cutoff either only during pregnancy, both during 
and up to 12 months after pregnancy, or at each three time-points. 
Conclusion: Maternal depressive symptoms during pregnancy, in the first year postpartum and in early 
childhood are associated with poorer child neurodevelopment. Our findings further suggest that antenatal 
and post-pregnancy depression have additive effects on neurodevelopment. Children of mothers with the 
most chronic and severe depressive symptoms during pregnancy had the most neurodevelopmental 
disadvantages. Our findings emphasize the adverse effects of maternal depression during and after 
pregnancy and in early childhood on child neurodevelopment. 
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INTRODUCTION 
Approximately 20% of women experience clinically relevant depressive symptoms during pregnancy(Lahti 
et al., 2017; Molyneaux, Poston, Ashurst-williams, & Howard, 2014). In over 40% of them, the symptoms 
continue postpartum(Heron, O’Connor G., Evans, Golding, & Glover, 2004), and 80% of women with 
postpartum depression have subsequent depressive episodes(Halligan, Murray, Martins, & Cooper, 2007). 
Depressive symptoms not only complicate maternal health during and after pregnancy but also predict low 
birth weight(Jarde et al., 2016), preterm birth(Grigoriadis et al., 2013; Jarde et al., 2016; Pesonen et al., 
2016), caesarean section delivery(Chung, Lau, Yip, Chiu, & Lee, 2001), decreased breastfeeding 
rates(Grigoriadis et al., 2013), and suboptimal mother-child attachment development(Misri & Kendrick, 
2008).  
According to the Developmental Origins of Health and Disease (DOHaD)-hypothesis(Barker, 
2007), maternal depression during and after pregnancy may also affect child neurodevelopment through 
developmental programming, permanently changing the structure and functioning of organs and body’s 
biological feedback systems, thereby compromising child neurodevelopment. Accordingly, maternal 
depression during pregnancy has been associated with structural brain changes in child prefrontal 
cortex(Sandman, Buss, Head, & Davis, 2015) frontal and inferior temporal areas(Lebel et al., 2016), and 
amygdala(Rifkin-Graboi et al., 2013), and in neural connectivity between amygdala and fronto-striatal 
areas(Qiu et al., 2015; Scheinost et al., 2017; Soe et al., 2017). Maternal depression postpartum has been 
associated with child cortical thickness and white matter diffusivity in right superior frontal areas (Lebel et 
al., 2016). 
Furthermore, several studies have shown that maternal depressive symptoms during and 
after pregnancy may be  associated with poorer neurodevelopmental outcomes in the offspring(Carter, 
Garrity-Rokous, Chazan-Cohen, Little, & Briggs-Gowan, 2001; El Marroun et al., 2016; Evans et al., 2012; 
Gerardin et al., 2011; Grace, Evindar, & Stewart, 2003; Hay, Pawlby, Waters, & Sharp, 2008; Y. Lin et al., 
2017; Räikkönen et al., 2015; Schechter et al., 2016; van der Waerden et al., 2017; Weikum, Oberlander, 
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Hensch, & Werker, 2012). In one of the largest such studies, clinically relevant maternal depressive 
symptoms at 18
th
  and 32
nd
 gestational weeks associated with lower intelligence quotient (IQ) in 8-year-old 
children(Evans et al., 2012), while maternal depression at 8 weeks to 8 months or at 21 to 33 months after 
pregnancy did not predict child IQ. Children whose mothers reported clinically relevant depressive 
symptoms across all these measurement points had the lowest IQ. In another large study, maternal 
depressive symptoms at gestation week 20 was associated with child global executive functioning and 
shifting problems at age 4 years but not with non-verbal cognition at age 5 years or neuropsychological 
functioning at 7 years(El Marroun et al., 2017). The associations were independent of maternal depressive 
symptoms 2 months or 3 years after childbirth. However, independent effects of maternal depressive 
symptoms after childbirth or additive effects of maternal depressive symptoms across timepoints were not 





  gestational weeks up to 5 years after childbirth were independently associated 
with lower IQ scores in 6-year-old children. In contrast, when adjusting for maternal antenatal anxiety, 
depressive symptoms concurrent to measuring child IQ and perinatal and sociodemographic covariates, 
child IQ was not associated with maternal depressive symptoms which were elevated only during 
pregnancy or only after childbirth. Furthermore, some smaller studies have reported null associations 
between maternal depressive symptoms during(Hay et al., 2008; Ibanez et al., 2015; Nulman et al., 2012) or 
after(Kurstjens & Wolke, 2001) pregnancy with child neurodevelopment or associations with even better 
outcomes(DiPietro, Novak, Costigan, Atella, & Reusing, 2006; Plamondon et al., 2015). 
No previous studies have included measurements of depressive symptoms throughout 
pregnancy. Hence, it remains unknown if there is a specific neurodevelopmental vulnerability window for 
maternal antenatal depressive symptoms, or whether consistently elevated depressive symptoms during 
pregnancy exert the most detrimental effects. As only two studies measured depressive symptoms during 
and after pregnancy and up to child’s preschool age(Evans et al., 2012; van der Waerden et al., 2017), it 
also remains unclear if maternal depressive symptoms during pregnancy, postpartum and early childhood 
periods exert different, independent or additive effects on child neurodevelopment.  
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Against this background, we tested whether maternal depressive symptoms, measured 
biweekly throughout pregnancy, twice up to 12 months postpartum, and when the child was 1.9-5.7-year-
old, associated with child developmental milestones in early childhood in a large prospective cohort of 
Finnish mothers and children. Consecutive measurements of depressive symptoms allowed us to address if 
associations varied by pregnancy stage, by pregnancy, postpartum and early childhood periods, and if 
consistently elevated levels of depressive symptoms throughout pregnancy, and/or throughout pregnancy 
to early childhood exerted most detrimental effects. 
We hypothesized that maternal depressive symptoms during and after pregnancy and in 
early childhood would be associated with lower developmental milestone scores in children. We also 
hypothesized that depressive symptoms during pregnancy would be specifically associated with poorer 
child neurodevelopment, and that chronically elevated maternal depressive symptoms from pregnancy to 
early childhood would predict the poorest neurodevelopmental outcomes. The scale we used to measure 
child developmental milestones, the Ages and Stages Questionnaire (ASQ), measures fine and gross motor, 
problem solving, communication and personal/social skills. Although findings are inconclusive, maternal 
depression during pregnancy has been associated with poorer child general problem-solving skills and with 
poorer psychomotor, social and communicative development(Evans et al., 2012; Koutra et al., 2017; Y. Lin 
et al., 2017; Weikum et al., 2012). Hence, we hypothesized that maternal depression would be associated 
with poorer child neurodevelopmental outcomes across all domains. 
  
Page 5 of 35 Depression and Anxiety
Corresponding Author: Marius Lahti-Pulkkinen. 6 
 
METHODS 
Originally, 5332 pregnant women were recruited to the Prediction and Prevention of Pre-eclampsia and 
Intrauterine Growth Restriction (PREDO)-study when visiting antenatal clinics at study hospitals in Southern 
and Eastern Finland for first ultrasound screening. Of them, 547 either withdrew participation during 
pregnancy or had untraceable child’s birth dates from Finnish Medical Birth Register (MBR)/hospital 
records. These women were excluded from the study sample and may include miscarriages and stillbirths 
not identified due to missing register data.  An additional 8 women were excluded since a miscarriage or 
stillbirth was identified from MBR. 
Of the 4777 women who gave birth to a singleton live child in 2006-2010, 3,402(71.2%) 
completed the biweekly depressive symptoms questionnaire during pregnancy, and of these 3,312(97.4%) 
at either of the two assessments that took place up to 12 months after pregnancy [at 1
st
 assessment at 
mean=2.41 weeks postpartum;standard deviation(SD)=1.2;range:0.1-18.0 weeks postpartum and/or at 2
nd
 
assessment at mean=28.3 weeks postpartum;SD=4.2;range:18.4-54.3 weeks postpartum], and 
2,667(78.4%) at the child developmental follow-up at child ages 1.9 to 5.7 years. We have previously 
reported the study design and follow-up attrition(Girchenko et al., 2017). Of the women with depressive 
symptoms data during or after pregnancy or at developmental follow-up, 2,231, 2,192 and 2,170, 
respectively, had child developmental milestones data at child’s mean age 3.5(SD=0.7;range:1.9- 5.7) years. 
Supplemental Table 1 shows comparisons of participants and non-participants. 
All participating women signed informed consents. Ethical committees of the Helsinki and 
Uusimaa Hospital District approved the study protocol. 
Maternal depressive symptoms 
The Center for Epidemiological Studies Depression Scale (CES-D)(Radloff, 1977) was completed by the 
women biweekly (every two weeks) up to 14 times throughout pregnancy between 12-13 and 38-39 
gestational weeks/delivery and twice up to 12 months after pregnancy. The CES-D comprises 20 questions, 
rated from none(0) to all(3) of the time on depressive symptoms during the past week. A score of ≥16 
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indicates risk for clinical depression. The CES-D yields four subscales on depressed affect, somatic 
symptoms, interpersonal problems and a reverse-scored scale on well-being. We also tested whether any 
associations of antenatal depressive symptoms with child neurodevelopment were specific to somatic 
symptoms that may be a consequence of pregnancy rather than reflect depression, or if the other subscales 
also showed significant associations. 
In the early childhood follow-up, the women completed the Beck Depression Inventory-II 
(BDI-II)(Beck, Steer, & Brown, 1996), which comprises 21 items assessing depressive symptoms during the 
previous fortnight. Each item contains four statements, rated from 0 to 3, reflecting increasing symptom 
severity. A score of ≥14 indicates at least mild depression.  
Both depression scales have good psychometric properties(Beck et al., 1996; Radloff, 1977; 
Vilagut, Forero, Barbaglia, & Alonso, 2016). The CES-D has been validated in pregnant populations(Maloni, 
Park, Anthony, & Musil, 2005; Natamba et al., 2014). In our sample, the Cronbach’s alphas of the CES-D 
during and after pregnancy varied from 0.88 to 0.92. For the BDI-II, it was 0.90.  
Child developmental milestones 
The ASQ Third edition (translated into Finnish, back-translated and publisher approved) is a reliable and 
valid tool with high sensitivity and specificity for screening children requiring further developmental 
assessment(Squires & Bricker, 2009; Squires, Bricker, & Potter, 1997). It includes separate questionnaires 
for 21 age groups between 2 and 60 months of age. Each age-specific questionnaire includes 30 age-
appropriate items measuring communication, gross motor, fine motor, problem solving and personal/social 
(solitary social play and play with toys and other children) skills (Squires & Bricker, 2009). 
Each of the five domains domain comprises six questions with response ‘yes’ (scored 10) 
indicating the child can master the skill, ‘sometimes’ (scored 5) if the skill is emerging/occasional, and ‘not 
yet’ (scored 0) if the child cannot perform the skill. Subscale scores range from 0 to 60, with the highest 
value indicating mastering all the skills in the domain. The Finnish version of the ASQ has not yet been 
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normed. Hence, we used the raw ASQ total score, the mean of the subscale scores, as our primary outcome 
and the five raw subscale scores as secondary outcomes.  
 
Covariates  
These included maternal age at childbirth (years), occupation (entrepreneur/senior clerical/lower clerical, 
manual worker, student, retired or other) parity (primiparous/multiparous), maternal smoking during 
pregnancy (did not smoke/quit during first trimester/smoked throughout), type 1 diabetes (yes/no), 







)], hypertensive pregnancy disorders (pre-
eclampsia/gestational hypertension; yes/no), and gestational diabetes (yes/no), family structure 
(cohabiting/married vs. living alone) child’s sex, gestational length (weeks), and birthweight (grams), with 
data extracted from hospital records and/or MBR; maternal history of physician-diagnosed depression 
before pregnancy (yes/no), psychotropic medication (antidepressants/other [barbiturates, sedatives, 
antipsychotics, mood stabilizers]/no) and alcohol use during pregnancy (yes/no)  and education level 
(basic/secondary vs. tertiary) were self-reported in early pregnancy, on average at 13.8 weeks (SD=4.0 
weeks) of gestation. Child’s age at follow-up (years) was calculated from the ASQ completion date and birth 
date. Participants with missing values in categorical covariates were dummy-coded to their own category. 
 
Statistical analyses  
Associations between maternal depressive symptoms during pregnancy (trimester-weighted-mean across 
14 measurements) and up to 12 months after pregnancy (mean of two measurements) and in early 
childhood and child’s ASQ total score were tested using Tobit and logistic regressions. Tobit regression 
accounts for the ceiling effect resulting from the ASQ not distinguishing between children mastering all age-
specific skills. Depressive symptoms were treated in these analyses both as continuous [square-root 
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transformed and standardized (mean=0;SD=1) and dichotomized at cutoffs indicating clinically relevant 
symptoms. ASQ total score was also used as a continuous variable and dichotomized at -1SD based on rank-
normalized values according to Blom’s formula, indicating mild developmental delay. 
We then tested associations between maternal depressive symptoms during each period 
with child ASQ subscale scores using ordinal logistic regressions, because each ASQ item is measured 
ordinally yielding subscale scores ranging from 0 to 60. 
With Tobit and/or logistic regressions, we tested (1) if maternal depressive symptoms during 
pregnancy showed gestation-week-specific effects on child ASQ total score, (2) if CES-D subscale scores 
during pregnancy were associated with children’s total ASQ score, and (3) if child’s ASQ total score 
decreased and odds for scoring below -1SD in ASQ total score increased according to the number of times 
the mother reported clinically relevant depressive symptoms across pregnancy trimesters (0/1/2-3).  
With latent profile analyses (LPA), we identified time-varying trajectories in maternal biweekly-assessed 
depressive symptoms during pregnancy and tested with Tobit and logistic regressions if ASQ total score and 
the proportion of children with ASQ total score below -1SD differed between the groups identified by LPA.  
Next, we tested with Tobit regression if child’s ASQ total score differed between the groups of women who 
during pregnancy, up to 12 months after pregnancy and in early childhood did not report clinically relevant 
depressive symptoms (referent) and who reported clinically relevant symptoms at any time point.  
For all these analyses, we present unstandardized regression coefficients (B) and/or odds 
ratios (OR) and 95% confidence interval (95%CI) from models adjusted for child’s age and sex, and further 
for maternal age, parity, education, occupation, history of depression before pregnancy, psychotropic 
medication use, alcohol use and smoking during pregnancy, early pregnancy BMI and hypertensive and 
diabetic pre-pregnancy and pregnancy disorders, family structure, gestation length, and infant’s 
birthweight adjusted for sex and gestation length.  
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Finally, with Tobit regression models, we examined whether the effects of continuously 
treated maternal depressive symptoms during pregnancy, postpartum or in early childhood were 
independent of each other by controlling for the effects of depressive symptoms at either of the other time 
points, along with child sex and age at follow-up.   
Page 10 of 35Depression and Anxiety
Corresponding Author: Marius Lahti-Pulkkinen. 11 
 
RESULTS 
Supplemental Table 2 shows the sample characteristics, Supplemental Table 3 the associations of the 
covariates with maternal depressive symptoms and Supplemental Table 4 with child developmental 
milestones. Maternal biweekly depressive symptoms during pregnancy were highly correlated(r=0.50-
0.80;all p<0.001). Trimester-weighted mean depressive symptoms during pregnancy correlated also 
significantly with mean depressive symptoms up to 12 months after pregnancy(r=0.66;p<0.001) and in early 
childhood(r=0.45;p<0.001).  
Table 1 shows that higher mean maternal depressive symptoms during pregnancy and 
symptoms that were above the clinical cutoff associated with lower ASQ total score and higher odds of 
scoring below the -1SD cutoff on the total ASQ scale across both adjustment models. Higher maternal 
depressive symptoms during pregnancy also associated with lower ASQ subscale scores on gross and fine 
motor, communication, problem solving and personal/social skills across adjustment models (Supplemental 
Table 5). Furthermore, all maternal CES-D subscale scores during pregnancy, higher depressed affect, 
somatic symptoms and interpersonal problems and lower well-being, associated with significantly lower 
child total ASQ scores (Supplemental Table 6).  
The LPA revealed four groups demonstrating highly stable antenatal depressive symptom 
levels (Akaike Information Criterion=177252.50;p=0.05) as the best descriptor of depressive symptoms 
across pregnancy (Figure 1). The two groups with lower depressive symptoms did not have clinically 
relevant symptomatology, while the two groups with higher depressive symptoms had subthreshold levels 
and levels indicating clinically relevant symptomatology. Figure 1 also shows that children whose mothers 
had consistently clinically relevant depressive symptoms during pregnancy had the lowest ASQ total scores 
and the highest proportion and odds of scoring below -1SD on the ASQ total scale. Supplemental Table 7, 
which shows associations between biweekly depressive symptoms scores during pregnancy and child ASQ 
total score, further emphasizes that the associations were independent of covariates and not gestation-
week specific. Yet, child ASQ total scores decreased and the proportion and odds for having ASQ total 
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scores below -1SD increased linearly according to the number of pregnancy trimesters (0/1/2-3) maternal 
depressive symptoms were above the clinical cutoff score (Figure 2). 
Table 1 shows that higher maternal depressive symptoms up to 12 months after pregnancy 
and in early childhood and symptoms above the clinical cutoff during these time points associated with 
lower ASQ total score and higher odds of scoring below the -1SD cutoff on the total ASQ in both models. 
Higher maternal depressive symptoms up to 12 months after pregnancy and in early childhood also 
significantly associated with lower scores on the ASQ gross and fine motor, communication, problem 
solving and personal/social skills subscales (Supplemental Table 8).  
Table 2 shows that of the 2,136 women with depressive symptoms data at all three time 
points, 437(20.5%) scored above the clinical cutoff during pregnancy, 389(18.2%) up to 12 months after 
pregnancy, and 178(8.3%) in early childhood. Compared to the children of women who did not report 
clinically relevant depressive symptoms at any time point, child ASQ total scores were significantly lower 
for the following three groups: women with depressive symptom scores above the clinical cutoff only 
during pregnancy, both during pregnancy and up to 12 months after pregnancy, and at all three time points 
(Table 2). 
Supplemental Table 9 shows that when treated as continuous scores, maternal depressive 
symptoms during pregnancy, postpartum and in early childhood each predicted lower child developmental 
milestone scores independently of maternal depressive symptoms at both of the other time points. 
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DISCUSSION 
Higher maternal depressive symptoms during and after pregnancy associated with lower developmental 
milestones total score and subscale scores in fine and gross motor, communication,  problem solving and 
personal/social skills in 1.9 to 5.7-year-old children. The pregnancy effects were independent of gestation 
week: children of mothers with consistently clinically relevant depressive symptoms during pregnancy had 
the lowest developmental milestones scores. Correspondingly, children whose mothers reported clinically 
relevant symptoms at two or three pregnancy trimesters had more neurodevelopmental disadvantage than 
children whose mothers reported clinically relevant symptoms during one or zero trimesters. Our findings 
were independent of important covariates that have been associated with depressive symptoms and/or 
poorer neurodevelopment either in this study or previously, including maternal history of physician-
diagnosed depression, early pregnancy BMI, pregnancy disorders, psychotropic medication and substance 
use during pregnancy, age, parity, education, occupation, family structure, child’s sex, age, gestation length 
and birth weight, and of somatic changes accompanying pregnancy included in depressive symptoms. 
Our findings verify previous findings that maternal depressive symptoms measured once or 
twice during pregnancy carry adverse neurodevelopmental consequences on children(Van den Bergh et al., 
2017). Yet, our findings add significantly to this literature by showing that child neurodevelopmental 
performance worsened according to the chronicity and severity of maternal depressive symptoms during 
pregnancy. 
Apart from antenatal depression, also higher maternal depressive symptoms up to 12 
months after pregnancy and in early childhood associated with lower developmental milestones total score 
and lower scores across all neurodevelopmental domains in children. Maternal depressive symptoms after 
pregnancy clearly influenced child neurodevelopment. The after pregnancy effects were additive to those 
during pregnancy: children whose mothers had chronically elevated depressive symptoms during and after 
pregnancy had the poorest developmental milestones scores. Compared to children whose mothers never 
had clinically significant depressive symptoms, neurodevelopmental scores were significantly worse for 
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children whose mothers had clinically relevant depressive symptoms either only during pregnancy, both 
during and up to 12 months after pregnancy, or across all three developmental stages. Children whose 
mothers had clinically relevant depressive symptoms only after pregnancy trended to fare worse but did 
not differ systematically from children of mothers not reporting clinically relevant depressive symptoms at 
any developmental stage. Only two previous studies have tested similar accumulation of depressive 
symptoms during and after pregnancy(Evans et al., 2012; van der Waerden et al., 2017). Our findings agree 
with theirs by showing poorest neurodevelopment in children whose mothers were chronically depressed 
during and after pregnancy. Our findings with categorically defined depression also confirm their 
conclusion that “the postnatal period is not a sensitive one for the effect of maternal depression on child 
cognitive development”(Evans et al., 2012). Nevertheless, our findings partially contrast one of these 
studies(van der Waerden et al., 2017) but correspond with the other (Evans et al., 2012) by showing that 
high maternal depressive symptoms occurring specifically during pregnancy affect child neurodevelopment.  
Furthermore, when treated continuously, maternal depressive symptoms during pregnancy, postpartum 
and in early childhood each predicted poorer child neurodevelopment independently of each other. These 
findings confirm that the effects of maternal depressive symptoms during pregnancy on child 
neurodevelopment were specific to the prenatal period but, in contrast to the above-mentioned findings, 
also suggest specific effects of maternal depressive symptoms postpartum and in early childhood. 
However, the high stability of depressive symptoms, as shown by their high intercorrelations across time 
points, makes it difficult to distinguish antenatal, postpartum and early childhood depression effects and 
may have led to multicollinearity problems in the analyses. Hence, the independence of these effects must 
be interpreted with caution. Yet, we also show that the additive effects of depressive symptoms during and 
after pregnancy follow a linear pattern and the effects of maternal depression during and after pregnancy 
are independent of important covariates, including cardiometabolic pregnancy disorders which most 
previous studies did not account for. 
Our findings emphasize the role of maternal depression during pregnancy on child 
neurodevelopment. This supports the DOHaD-hypothesis, which suggests that prenatal exposure to 
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environmental adversity such as maternal depression may “program” child neurodevelopment(Barker, 
2007), possibly through its effects on brain development(Van den Bergh et al., 2017). Furthermore, 
maternal depressive symptoms during pregnancy are also associated with maternal biomarkers with 
offspring neurodevelopmental relevance, including polyunsaturated fatty acids(P.Y. Lin, Chang, Chong, 
Chen, & Su, 2017), proinflammatory cytokines(Christian, Franco, Glaser, & Iams, 2009), thyroid 
hormones(Bunevicius et al., 2009), cortisol(Seth, Lewis, & Galbally, 2016), and placental morphology(Lahti-
Pulkkinen et al., 2018), and with elevated placental corticotrophin releasing hormone(Moog et al., 2016), 
and placental mRNA gene expression levels of glucocorticoid (NR3C1) and mineralocorticoid (NR3C2) 
receptors(Reynolds et al., 2015; Räikkönen et al., 2015). These findings suggest that the mechanisms are 
complex and may include structural and functional alterations at the materno-placento-fetal unit. It has 
also been suggested that maternal depression during pregnancy fails to prime mother-child 
responsiveness(Pearson, Cooper, Penton-Voak, Lightman, & Evans, 2010), and that the main mechanism 
linking maternal depression after pregnancy and child neurodevelopment is the sub-optimally developing 
mother-child attachment(Carter et al., 2001).  
Strengths of our study include the prospective design, large and well-characterized sample, 
repeated depressive symptoms measurements throughout and after pregnancy, and a well-validated 
measure of child developmental milestones. Yet, nearly half of the cohort was lost to follow-up, and the 
ethnic homogeneity of our sample and use of single informant and questionnaire on child 
neurodevelopment limit the generalizability of our findings. While the attrition level was typical to 
longitudinal studies, it was not independent of maternal or child characteristics and maternal depressive 
symptoms were higher among non-participants. Hence, a selection bias in participation may have 
influenced our findings. Nevertheless, the prevalence of maternal antenatal antidepressant use in our 
sample corresponded to the general Finnish population(Malm et al., 2016), supporting the 
representativeness of our sample. On the other hand, while we focused on the effects of maternal 
depressive symptoms on child neurodevelopment, depression is highly comorbid with anxiety also in the 
perinatal period(Falah-Hassani, Shiri, & Dennis, 2017), and maternal antenatal anxiety has also been shown 
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to affect child neurodevelopment(Buss, Davis, Hobel, & Sandman, 2011; O’Donnell et al., 2017; Van den 
Bergh et al., 2017). Hence, further studies disentangling the unique effects of maternal depression and 
anxiety on child neurodevelopment are warranted. A further limitation is that we had no paternal antenatal 
depressive symptoms data. Further studies assessing also paternal depressive symptom trajectories and 
using multiple informants and/or neuropsychological tests on child neurodevelopment are needed. 
Furthermore, we used cutoff scores of depressive symptoms in many analyses. Cutoff scores are sensitive 
to the population studied and also other cutoffs have been suggested for the CES-D(Vilagut et al., 2016). 
However, our findings were similar whether we used categorical or continuous depressive symptom 
assessments. 
Clinically, our findings implicate that intervention in early pregnancy may benefit both 
mothers and children: early treatment may prevent the accumulative cascade of depressive symptoms 
from pregnancy onwards, which may all possibly reflect positively on child neurodevelopment.   
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CONCLUSION 
Maternal depressive symptoms during and up to 12 months after pregnancy and in early childhood 
associate significantly with lower child developmental milestones scores. Our longitudinal study suggests 
that the effects of depressive symptoms during and after pregnancy on child neurodevelopment are 
additive: children of women with the most chronic and severe depressive symptoms during and after 
pregnancy have the most neurodevelopmental disadvantages. 
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Table 1. Maternal depressive symptoms during and up to 12 months after pregnancy and in early childhood 
and child developmental milestones. 
Maternal depressive symptoms Child Ages and Stages 
Questionnaire score 
 Child Ages and Stages 
Questionnaire score ≤-1SD 
 
 B (95% CI) p OR (95% CI) p 
Pregnancy mean CES-D score (n=2231)    
 Model 1 -0.99 (-1.28; -0.71) <0.001 1.40 (1.25; 1.57) <0.001 
 Model 2 -0.84 (-1.13; -0.55) <0.001 1.33 (1.17; 1.50) <0.001 
Pregnancy mean CES-D score ≥16    
 Model 1 -1.87 (-2.56; -1.18) <0.001 2.05 (1.60; 2.64) <0.001 
 Model 2 -1.56 (-2.26; -0.87) <0.001 1.92 (1.47; 2.51) <0.001 
After pregnancy mean CES-D score (n=2192)    
 Model 1 -1.05 (-1.34; -0.76) <0.001 1.36 (1.21; 1.53) <0.001 
 Model 2 -0.89 (-1.18; -0.60) <0.001 1.29 (1.14; 1.45) <0.001 
After pregnancy mean CES-D score ≥16    
 Model 1 -2.13 (-2.86; -1.40) <0.001 1.85 (1.42; 2.41) <0.001 
 Model 2 -1.80 (-2.53; -1.07) <0.001 1.68 (1.28; 2.21) <0.001 
Early childhood BDI-II score (n=2170)    
 Model 1 -0.97 (-1.26; -0.69) <0.001 1.27 (1.13; 1.42) <0.001 
 Model 2 -0.85 (-1.14; -0.57) <0.001 1.22 (1.09; 1.38) 0.001 
Early childhood BDI-II score ≥14    
 Model 1 -2.04 (-2.92; -1.17) <0.001 1.71 (1.26; 2.34) 0.001 
 Model 2 -1.77 (-2.64; -0.90) <0.001 1.61 (1.17; 2.23) 0.004 
CES-D=Center for Epidemiological Studies Depression Scale; BDI=Beck Depression Inventory-II; ASQ=Ages 
and Stages Questionnaire; SD=standard deviation; B=unstandardized regression coefficient; OR=odds ratio; 
95% CI=95% confidence interval 
For continuous depression scores the B:s and 95% CI:s from Tobit regression analyses refer to one-point 
change in ASQ scores per SD unit change in maternal depressive symptoms; for categorical depression 
variables the B:s and 95% CI:s refer to differences in ASQ scores of children of mothers with vs. without 
clinically relevant depressive symptoms 
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For continuous depression scores the ORs and 95% CIs from logistic regression analyses show the odds of 
belonging to the group scoring ≤-1SD in ASQ per SD unit change in maternal depressive symptoms; for 
categorical depression variables the ORs and 95% CIs show the odds of belonging to the group scoring ≤-
1SD vs. >-1SD in ASQ for the children of mothers with vs. without clinically relevant depressive symptoms. 
Model 1 is adjusted for child’s age and sex. 
Model 2 further for maternal age, parity, education, occupation, history of depression, antidepressant and 
other psychotropic medication use, alcohol use and smoking during pregnancy, type 1 diabetes, chronic 
hypertension, early pregnancy body mass index, gestational diabetes, and hypertensive pregnancy 
disorders, family structure, gestational length, and child’s birthweight for gestation. 
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Table 2. The pattern of maternal depressive symptom scores above and below the clinical cutoff over time 
and child developmental milestones (n=2136)  
During 
pregnancy 












SE 95 % CI p
b
 
No No No 1436 67.2 54.33 0.16 54.01-54.65 ref 
Yes No No 168 7.9 53.18 0.48 52.25-54.11 0.04
c
 
No Yes No 131 6.1 53.52 0.54 52.46-54.58 0.15 
No No Yes 97 4.6 53.34 0.63 52.10-54.57 0.17 
Yes Yes No 142 6.6 




Yes No Yes 45 2.1 53.43 0.92 51.62-55.23 0.32 
No Yes Yes 34 1.6 52.36 1.06 50.28-54.44 0.051 
Yes Yes Yes 82 3.8 




SE=standard error; 95% CI=95% confidence interval 
a
Adjusted for child’s age and sex (estimated marginal mean). 
b
p-values in Tobit regression model 1 with the group with mothers whose depressive symptom scores were 
never above the clinical cutoff as a referent. 
c
p-value in Tobit regression model 2 =0.07. 
d
p-values in Tobit regression model 2 <0.001. 
For different adjustment models in the Tobit regressions, please see footnote in Table 1. 
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FIGURE LEGENDS 
Figure 1.  
Panel A: Latent profile analysis on the course of maternal depressive symptoms during pregnancy. The 
figure shows the mean depressive symptom scores at different gestational weeks in four groups of mothers 
with consistently low, subthreshold and clinically relevant depressive symptoms.  
Panel B: Estimated marginal means of ASQ scores in four groups identified by latent profile analysis.  
Panel C: Proportion of children with ASQ scores ≤-1SD. Error bars refer to 95% CIs.  
Numbers refer to unstandardized regression coefficients of Tobit regression analyses (Panel B) and odds 
ratios (Panel C) and their 95% CIs with the group “Low1: no clinically relevant depressive symptom” as the 
referent and are from models adjusting for child’s age and sex.  
ASQ=Ages and Stages Questionnaire; CES-D=Center for Epidemiological Studies Depression Scale; 
SD=standard deviation; 95% CI=95% confidence interval 
Figure 2.  
Additive effects of maternal trimester-specific depressive symptoms during pregnancy on child 
developmental milestones.  
Panel A: Estimated marginal means of the child Ages and Stages Questionnaire (ASQ) scores according to 
the number of pregnancy trimesters during which the mother had mean depressive symptoms above the 
clinical cutoff of ≥ 16 are shown. Estimated marginal means are adjusted for child's age and sex.  
Panel B: Percentages of children having the ASQ scores of ≤-1SD according to the number of pregnancy 
trimesters during which the mother had mean depressive symptoms above the clinical the clinical cutoff of 
≥ 16.  
Error bars refer to 95% confidence intervals (95% CIs) and numbers to unstandardized regression 
coefficients of Tobit regression analyses (Panel A) and odds ratios (Panel B) and their 95% CIs with the 
group with mothers whose trimester-specific depressive symptom scores were not above the clinical cutoff 
at any trimester as a referent and are from models adjusting for child’s age and sex.  
 
Page 30 of 35Depression and Anxiety
Table 1. Maternal depressive symptoms during and up to 12 months after pregnancy and in early childhood 
and child developmental milestones. 
Maternal depressive symptoms Child Ages and Stages 
Questionnaire score 
 Child Ages and Stages 
Questionnaire score ≤-1SD 
 
 B (95% CI) p OR (95% CI) p 
Pregnancy mean CES-D score (n=2231)    
 Model 1 -0.99 (-1.28; -0.71) <0.001 1.40 (1.25; 1.57) <0.001 
 Model 2 -0.84 (-1.13; -0.55) <0.001 1.33 (1.17; 1.50) <0.001 
Pregnancy mean CES-D score ≥16    
 Model 1 -1.87 (-2.56; -1.18) <0.001 2.05 (1.60; 2.64) <0.001 
 Model 2 -1.56 (-2.26; -0.87) <0.001 1.92 (1.47; 2.51) <0.001 
After pregnancy mean CES-D score (n=2192)    
 Model 1 -1.05 (-1.34; -0.76) <0.001 1.36 (1.21; 1.53) <0.001 
 Model 2 -0.89 (-1.18; -0.60) <0.001 1.29 (1.14; 1.45) <0.001 
After pregnancy mean CES-D score ≥16    
 Model 1 -2.13 (-2.86; -1.40) <0.001 1.85 (1.42; 2.41) <0.001 
 Model 2 -1.80 (-2.53; -1.07) <0.001 1.68 (1.28; 2.21) <0.001 
Early childhood BDI-II score (n=2170)    
 Model 1 -0.97 (-1.26; -0.69) <0.001 1.27 (1.13; 1.42) <0.001 
 Model 2 -0.85 (-1.14; -0.57) <0.001 1.22 (1.09; 1.38) 0.001 
Early childhood BDI-II score ≥14    
 Model 1 -2.04 (-2.92; -1.17) <0.001 1.71 (1.26; 2.34) 0.001 
 Model 2 -1.77 (-2.64; -0.90) <0.001 1.61 (1.17; 2.23) 0.004 
CES-D=Center for Epidemiological Studies Depression Scale; BDI=Beck Depression Inventory-II; ASQ=Ages 
and Stages Questionnaire; SD=standard deviation; B=unstandardized regression coefficient; OR=odds ratio; 
95% CI=95% confidence interval 
For continuous depression scores the B:s and 95% CI:s from Tobit regression analyses refer to one-point 
change in ASQ scores per SD unit change in maternal depressive symptoms; for categorical depression 
variables the B:s and 95% CI:s refer to differences in ASQ scores of children of mothers with vs. without 
clinically relevant depressive symptoms 
For continuous depression scores the ORs and 95% CIs from logistic regression analyses show the odds of 
belonging to the group scoring ≤-1SD in ASQ per SD unit change in maternal depressive symptoms; for 
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categorical depression variables the ORs and 95% CIs show the odds of belonging to the group scoring ≤-
1SD vs. >-1SD in ASQ for the children of mothers with vs. without clinically relevant depressive symptoms. 
Model 1 is adjusted for child’s age and sex. 
Model 2 further for maternal age, parity, education, occupation, history of depression, antidepressant and 
other psychotropic medication use, alcohol use and smoking during pregnancy, type 1 diabetes, chronic 
hypertension, early pregnancy body mass index, gestational diabetes, and hypertensive pregnancy 
disorders, family structure, gestational length, and child’s birthweight for gestation. 
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Figure 1. "Panel A: Latent profile analysis on the course of maternal depressive symptoms during 
pregnancy. The figure shows the mean depressive symptom scores at different gestational weeks in four 
groups of mothers with consistently low, subthreshold and clinically relevant depressive symptoms. "Panel 
B: Estimated marginal means of ASQ scores in four groups identified by latent profile analysis. "Panel C: 
Proportion of children with ASQ scores ≤-1SD. Error bars refer to 95% CIs. "Numbers refer to 
unstandardized regression coefficients of Tobit regression analyses (Panel B) and odds ratios (Panel C) and 
their 95% CIs with the group “Low1: no clinically relevant depressive symptom” as the referent and are 
from models adjusting for child’s age and sex. "ASQ=Ages and Stages Questionnaire; CES-D=Center for 
Epidemiological Studies Depression Scale; SD=standard deviation; 95% CI=95% confidence interval  
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 Figure 2. Additive effects of maternal trimester-specific depressive symptoms during pregnancy on child 
 developmental milestones. Panel A: Estimated marginal means of the child Ages and Stages 
Questionnaire (ASQ) scores according to the number of pregnancy trimesters during which the mother had 
mean depressive symptoms above the clinical cutoff of ≥ 16 are shown. Estimated marginal means are 
 adjusted for child's age and sex. Panel B: Percentages of children having the ASQ scores of ≤-1SD 
according to the number of pregnancy trimesters during which the mother had mean depressive symptoms 
above the clinical the clinical cutoff of  ≥ 16. Error bars refer to 95% confidence intervals (95% CIs) and 
numbers to unstandardized regression coefficients of Tobit regression analyses (Panel A) and odds ratios 
(Panel B) and their 95% CIs with the group with mothers whose trimester-specific depressive symptom 
scores were not above the clinical cutoff at any trimester as a referent and are from models adjusting for 
 child’s age and sex.   
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